4.45
-0.05 (-1.11%)
| Previous Close | 4.50 |
| Open | 4.46 |
| Volume | 226,001 |
| Avg. Volume (3M) | 702,084 |
| Market Cap | 289,403,744 |
| Price / Sales | 1.41 |
| Price / Book | 4.32 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2026 |
| Profit Margin | -25.14% |
| Operating Margin (TTM) | -29.64% |
| Diluted EPS (TTM) | -0.850 |
| Quarterly Revenue Growth (YOY) | 2.90% |
| Total Debt/Equity (MRQ) | 65.85% |
| Current Ratio (MRQ) | 4.50 |
| Operating Cash Flow (TTM) | -25.75 M |
| Levered Free Cash Flow (TTM) | -17.03 M |
| Return on Assets (TTM) | -14.56% |
| Return on Equity (TTM) | -45.73% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Treace Medical Concepts, Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 0.5 |
| Average | -0.13 |
|
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 25.76% |
| % Held by Institutions | 62.73% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Gagnon Advisors, Llc | 30 Jun 2026 | 1,534,034 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |